Skip to content

A multi-center retrospective study on the occurrence risk of remnant gastric cancer based on the evaluation of the gastric mucosa and residual gastritis morphology after gastrectomy

A multi-center retrospective study on the occurrence risk of remnant gastric cancer based on the evaluation of the gastric mucosa and residual gastritis morphology after gastrectomy - Remnant gastritis classification for predicting remnant gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000055884
Enrollment
120
Registered
2024-10-30
Start date
2021-09-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer, Remnant Gastric CancerGastric Cancer, Remnant Gastric Cancer

Interventions

None listed

Sponsors

Kyoto Prefectural University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent gastrectomy or endoscopic submucosal dissection (ESD) for residual gastric cancer at our hospital or facilities participating in this study between January 1, 2000 and December 31, 2020.

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or may become pregnant. 2. Patients participating in clinical research with other invasions (including minor invasions) that are considered to be related to this study. 3. Patients judged to be inappropriate by the attending physician or research collaborator.

Design outcomes

Primary

MeasureTime frame
To reveal the relationship between the occurrence of remnant gastric cancer and the endoscopic findings of background remnant gastritis

Countries

Japan

Contacts

Public ContactTakeshi Kubota

University Hospital, Kyoto Prefectural University of Medicin Department of Digestive Surgery

tkubot@koto.kpu-m.ac.jp075-251-5527

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026